Inner earplug

By designing a fixed inner ear drug delivery plug, using passive drug delivery mechanism and anchoring characteristics, the problem of low efficiency of inner ear drug delivery in the prior art is solved, and the direct, safe and effective delivery of drugs is achieved, reducing the risk of side effects.

CN118948528APending Publication Date: 2024-11-15COCHLEAR LIMITED
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411206247.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2016-05-26
Filing Date
2017-05-17
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The prior art is difficult to target drug delivery to the inner ear safely and effectively, resulting in traditional drug delivery techniques that only allow limited amounts of drugs to reach the inner ear, increasing the risk of drug dosage and side effects.

Method used

A fixed inner ear drug delivery plug is designed to deliver the drug directly by inserting and fixing into the inner ear opening using a passive drug delivery mechanism and prevent it from exiting by anchoring features, including drug reservoirs and drug delivery tubes, using capillary force Or compressive force to control drug release.

Benefits of technology

The direct, safe and effective delivery of drugs to the inner ear is achieved, reducing drug dosage and side effects, and improving the effectiveness of treating inner ear diseases.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948528A_ABST
    Figure CN118948528A_ABST
Patent Text Reader

Abstract

The invention relates to an inner earplug. Embodiments generally relate to a fixable internal drug delivery plug or plug configured to be inserted into and secured (retained) in an opening of an inner ear of a recipient. A fixable internal drug delivery plug is configured to deliver a drug directly into the inner ear.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of the Chinese invention patent application with the international application date of May 17, 2017, the national application number of 201780032327.9, and the invention name of “Inner Ear Plug”.

[0002] CROSS-REFERENCE TO RELATED APPLICATIONS

[0003] This application claims priority to U.S. Non-Provisional Patent Application No. 15 / 165,165, filed May 26, 2016, the entire contents of which are incorporated herein by reference. Technical Field

[0004] The present invention relates generally to inner ear drug delivery. Background Art

[0005] For example, hearing loss, which can be due to many different causes, is generally of two types, conductive and / or sensorineural. Conductive hearing loss occurs when the normal mechanical pathways of the outer ear and / or middle ear are blocked (e.g., by damage to the ossicular chain or the ear canal). Sensorineural hearing loss occurs when there is damage to the inner ear or damage to the neural pathways from the inner ear to the brain. In some cases, hearing loss, particularly sensorineural hearing loss, is associated with (e.g., caused by) an inner ear disease. Summary of the invention

[0006] In one aspect of the present invention, a fixable inner ear drug delivery plug is provided. The fixable drug delivery plug includes: a body for insertion into an opening in the inner ear of a recipient; at least one passive drug delivery mechanism configured to deliver one or more drugs directly into the inner ear; and one or more anchoring features configured to fix the body in the inner ear opening.

[0007] In another aspect of the present invention, a method is provided. The method includes: inserting a drug delivery plug into an opening in an inner ear of a recipient, wherein the drug delivery plug extends through the opening; securing the drug delivery plug in the opening using one or more anchoring features formed in the drug delivery plug; and passively releasing a drug from the drug delivery plug directly into the inner ear. BRIEF DESCRIPTION OF THE DRAWINGS

[0008] Embodiments of the present invention are described herein with reference to the accompanying drawings, in which:

[0009] Figure 1A is a schematic diagram illustrating the anatomical structure of a recipient at a location where a fixable inner ear drug delivery plug may be implanted according to embodiments presented herein;

[0010] Figure 1B and Figure 1Cis a cross-sectional view of a fixable inner ear drug delivery plug according to an embodiment presented herein;

[0011] Figure 2 is a cross-sectional view of another fixable inner ear drug delivery plug according to embodiments presented herein;

[0012] Figure 3 is a cross-sectional view of another fixable inner ear drug delivery plug according to embodiments presented herein;

[0013] Figure 4 is a cross-sectional view of another fixable inner ear drug delivery plug according to embodiments presented herein;

[0014] Figure 5A and Figure 5B is a cross-sectional view of another fixable inner ear drug delivery plug according to embodiments presented herein;

[0015] Fig. 6A and Figure 6B is a cross-sectional view of another fixable inner ear drug delivery plug according to embodiments presented herein;

[0016] Fig. 7A and Figure 7B is a cross-sectional view of another fixable inner ear drug delivery plug according to embodiments presented herein;

[0017] Fig. 8A and 8B is a cross-sectional view of another fixable inner ear drug delivery plug according to embodiments presented herein;

[0018] Fig.9A and Fig. 9B is a cross-sectional view of another fixable inner ear drug delivery plug according to embodiments presented herein; and

[0019] Fig.10 is a cross-sectional view of another fixable inner ear drug delivery plug according to embodiments presented herein. DETAILED DESCRIPTION

[0020] Inner ear diseases include diseases that affect the auditory system and / or vestibular system of an individual. These inner ear diseases often cause or lead to various medical problems, such as hearing loss, vertigo, tinnitus, Meniere's disease, etc. It may be desirable to utilize local / targeted delivery to be designed to treat / solve potential inner ear diseases (e.g., biological substances or bioactive substances), chemicals, medicaments, nanoparticles, ions, DNA / RNA molecules, proteins, peptides, RNAi, etc. (generally referred to as "therapeutic substances" or simply "drugs" in this article) to solve these medical problems. Drugs can also be delivered to prevent infection, promote healing, retain hearing, prevent fibrosis, etc. Therefore, as used herein, "drugs" or "therapeutic substances" include but are not limited to bioactive substances, chemicals, or other deliverable substances for treatment, prevention, diagnosis, or other purposes, and these deliverable substances include active pharmaceutical ingredients (APIs) (e.g., antibiotics, anti-inflammatory drugs, antimicrobial agents, etc.).

[0021] Although the potential avenues for cochlear therapy are rapidly expanding, the inner ear remains a challenging organ for targeted delivery of drugs in a safe and effective manner. For example, traditional drug delivery techniques typically only allow a limited amount of drug to actually reach the inner ear, so it is necessary to increase the dose of the drug administered, which in turn increases the side effects of the corresponding drugs. Local delivery of drugs to the inner ear via one or more inner ear openings (e.g., round window, oval window, cochleostomy, etc.) improves these problems. Therefore, an embodiment of the present invention relates to a fixable internal drug delivery plug or plug, configured to be inserted into and fixed (retained) in an opening of the inner ear of an individual, and configured to deliver the drug directly into the inner ear. The individual in whom the fixable internal drug delivery plug is implanted is referred to herein as the "recipient" of the fixable internal drug delivery plug.

[0022] The fixable inner ear drug delivery plug according to an embodiment of the present invention may be used alone or in combination with any partially or fully implantable hearing prosthesis, such as a bone conduction device, a mechanical stimulator, an auditory brain implant, a cochlear implant, etc. However, for ease of description only, the fixable inner ear drug delivery plug is primarily described and is shown separately from any partially or fully implantable hearing prosthesis.

[0023] Before describing illustrative embodiments of the fixable internal drug delivery plug, reference is first made to Figure 1A Provide a brief description of the human anatomy of the recipient's ear.

[0024] like Figure 1AAs shown, the recipient's ear includes an outer ear 101, a middle ear 105, and an inner ear 107. In a fully functional ear, the outer ear 101 includes an auricle 110 and an ear canal 102. Sound pressure or sound waves 103 are collected by the auricle 110 and are directed into and through the ear canal 102. Disposed at the distal end of the ear canal 102 is an eardrum 104 that vibrates in response to the sound waves 103. The vibrations are coupled to an oval window or an oval window 112 through the bones of the middle ear 105, which are adjacent to a round window 121. The bones of the middle ear 105 include a malleus 108, an incus 109, and a stapes 111, collectively referred to as ossicles 106. The ossicles 106 are located in the middle ear cavity 113 and serve to filter and amplify the sound waves 103, thereby causing the oval window 112 to pivot (vibrate) in response to the vibrations of the eardrum 104. The vibration of the oval window 112 sets up waves of fluid movement of the perilymph within the cochlea 140, which forms part of the inner ear 107. In turn, such fluid movement activates tiny hair cells (not shown) inside the cochlea 140. Activation of the hair cells causes appropriate nerve impulses to be generated, and the nerve impulses are transmitted through spiral ganglion cells (not shown) and the auditory nerve 114 to the brain (also not shown), where they are perceived as sound.

[0025] The human skull is formed by several different bones that support various anatomical features. Figure 1A 1 is a temporal bone 115 located at the side and bottom of a recipient's skull 124. For ease of reference, the temporal bone 115 is referred to herein as having an upper portion 118 and a mastoid portion 120. The upper portion 118 includes the portion of the temporal bone 115 that extends above the auricle 110. That is, the upper portion 118 is the portion of the temporal bone 115 that forms the lateral surface of the skull. The mastoid portion 120, referred to herein as the mastoid 120, is located below the upper portion 118. The mastoid 120 is the portion of the temporal bone 115 that surrounds the middle ear 105.

[0026] like Figure 1A As shown, the semicircular canals 125 are three semicircular interconnected canals located adjacent to the cochlea 140. The semicircular canals 125 also form a part of the inner ear 107 and are in fluid communication with the cochlea 140 via the vestibule 129. The three semicircular canals include a horizontal canal 126, a posterior canal 127, and a superior canal 128. The canals 126, 127, and 128 are aligned approximately orthogonally to each other. Specifically, when the individual is in an upright position, the horizontal canal 126 is aligned approximately horizontally in the head, while the superior canal 128 and the posterior canal 127 are aligned approximately at a 45 degree angle to a vertical direction through the center of the individual's head.

[0027] Each semicircular canal is filled with a fluid called endolymph and contains motion sensors with tiny hairs (not shown) whose ends are embedded in a gelatinous structure called the cuboidal jar (also not shown). As the orientation of the skull changes, the endolymph is forced into different parts of the canal. The hairs detect when the endolymph passes through, and a signal is sent to the brain. Using these hair cells, the horizontal canals 126 detect horizontal head movement, while the upper canals 128 and the rear canals 127 detect vertical head movement.

[0028] As noted, embodiments of the present invention relate to a drug delivery plug for insertion into an opening in the inner ear of a recipient. The inner ear opening into which the drug delivery plug enters may include, for example, a natural opening (such as an oval window 112 or a circular window 121, each sealed by a membrane), or a surgically created opening (e.g., a cochleostomy or an opening surgically created in one of a plurality of semicircular canals). As further described below, in addition to including at least one passive drug delivery mechanism, the drug delivery plug also includes one or more anchoring features configured to fix (hold) the drug delivery plug in the inner ear opening. As further described below, one or more anchoring features are configured to substantially prevent the withdrawal or removal of the plug without surgical intervention (e.g., surgical removal of the plug). Therefore, a drug delivery plug according to an embodiment of the present invention is referred to as a fixable inner ear drug delivery plug, indicating that the plug: (1) is configured to deliver one or more drugs directly to (i.e., directly to) the inner ear of the recipient; and (2) is configured to be anchored in or otherwise substantially permanently fixed in the inner ear opening. The drug delivery mechanisms proposed herein are "passive" in that they do not utilize any active components (such as a pump) to deliver the drug to the recipient.

[0029] Figure 1B and Figure 1C 1 is a cross-sectional view of a fixable inner ear drug delivery plug 150 that can be inserted and fixed in, for example, an oval window 112, a circular window 121, an opening created by a cochleostomy or other surgery, etc. in the inner ear. For ease of description and unless otherwise specified, the oval window 112, the circular window 121, an opening created by a cochleostomy or other surgery, or any other opening into which a fixable inner ear drug delivery plug can be inserted and fixed are collectively referred to herein as an "inner ear opening".

[0030] Figure 1B The illustration shows a fixable inner ear drug delivery plug 150 separated from the inner ear opening, and Figure 1C The illustration shows a fixable inner ear drug delivery plug 150 positioned in an inner ear opening 160. As shown, the fixable inner ear drug delivery plug 150 includes an outer body 152 surrounding / defining an inner region 154 in which one or more drugs are disposed. Figure 1B and Figure 1C In the example of the embodiment, the inner region 154 is a reservoir for one or more liquid drugs. That is, the outer body 152 is a substantially impermeable element, forming a container for containing one or more liquid drugs.

[0031] exist Figure 1A and Figure 1B In an embodiment of the invention, the fixable inner ear drug delivery plug 150 has a proximal end 148 and a distal end 146. The distal end 146 is configured to be inserted through an opening 160 in a structure 162 of a recipient's inner ear (i.e., cochlea or semicircular canal) 164, while the proximal end 148 is configured to remain outside (outside) the inner ear. That is, when fully implanted / inserted, the first portion 166 of the fixable inner ear drug delivery plug 150 is disposed / positioned outside the inner ear 164, while the second portion 168 of the fixable inner ear drug delivery plug 250 is disposed inside (inside) the inner ear 164 (i.e., the fixable inner ear drug delivery plug 250 is configured to be partially inserted into the inner ear 164). As used herein, a fixable inner ear drug delivery plug, such as plug 150, is fully inserted / implanted when the distal end 146 of the plug is located in the inner ear 164, and the outer body 152 substantially fills the opening 160.

[0032] As noted, a fixable inner ear drug delivery plug according to an embodiment of the present invention, such as plug 150, includes a passive drug delivery mechanism that delivers one or more drugs directly into the inner ear. Figure 1A and Figure 1B In the embodiment of the invention, the passive drug delivery mechanism 174 is provided with a reservoir 154 and one or more drug delivery tubes / catheters 138. Figure 1C As shown, when the fixable inner ear drug delivery plug 150 is positioned in the opening 160, the drug delivery tubes 138 each extend from the reservoir 154 through the outer body 152 into the inner ear 164. Therefore, the drug in the reservoir 154 can leave the reservoir and enter the inner ear via the drug delivery tubes 138 (i.e., the drug delivery tubes provide a passage for one or more drugs to leave the reservoir and enter the inner ear). The drug delivery mechanism 174 is considered "passive" because it does not utilize any active components (such as a pump) to deliver the drug to the recipient.

[0033] It should be appreciated that the liquid drug disposed in the reservoir 154 can exit the reservoir and enter the inner ear via the delivery tube 138 due to various actions and / or forces. For example, in one embodiment, the drug exits the delivery tube 138 due to capillary forces. In certain such embodiments, in order to control the release of the liquid drug, the delivery tube 138 can include an inner coating or surfactant that changes the resistance of the inner surface to the flow of the liquid drug. For example, the inner surface of the delivery tube 138 can include an inner coating or surfactant that changes the surface hydrophobicity to change the drug release rate. In alternative embodiments, similar results can be obtained by adjusting the viscosity of the liquid drug using one or more additives.

[0034] In another embodiment, the liquid drug disposed in the reservoir 154 can exit the reservoir and enter the inner ear via the delivery tube 138 due, at least in part, to compression forces. For example, in one embodiment, the outer body 152 is resiliently flexible so as to be at least partially compressible, for example, during insertion through the opening 160. The compressibility of the outer body 152 can facilitate insertion of the plug 150 through the opening 160 (i.e., temporarily reducing the outer dimensions of the plug 150 during insertion), but such compression can also facilitate delivery of the drug via the drug delivery tube 138. More specifically, after the distal end 146 has passed through the opening 160, compressing the outer body 152 can in turn compress the reservoir 154 so as to force a portion of the drug in the reservoir to pass through the delivery tube 138. After the initial compression, the outer body 152 can return to its original shape, and any drug remaining in the reservoir 154 can exit the reservoir 154 via, for example, capillary forces as described above. In these embodiments, the outer bodies 152 can each be formed from a polymeric material, such as, for example, polydimethylsiloxane (PDMS) or other types of silicone.

[0035] In some examples, the distal end of one or more of the delivery tubes 138 may be sealed with a permeable membrane or a bioresorbable membrane so that the time frame of drug delivery can be controlled.

[0036] It should also be appreciated that in alternative embodiments, the fixable inner ear drug delivery plug can have a different number of drug delivery tubes. It should also be appreciated that the drug delivery tubes 138 can have a variety of different arrangements. For example, in one embodiment, the delivery tubes 138 can contain or be coated with a compound that prevents fibrosis growth, and / or be coated with various types of drugs. The delivery tubes 138 can be formed of the same or different materials as the outer body 152.

[0037] It should be appreciated that the reservoir 154 can include multiple different types of drugs. That is, according to embodiments of the present invention, multiple different drugs can be disposed in the reservoir 154 for delivery to a recipient. It should also be appreciated that the interior area 154 can include more than one reservoir, each reservoir being associated with one or more of the drug delivery tubes 138.

[0038] As noted, the fixable inner ear drug delivery plug 150 can be inserted into an opening 160, which can be any natural opening (e.g., the oval window 112 or the circular window 121) or a surgically created (artificial) opening in the inner ear. Figure 1A and Figure 1B The arrangement may be particularly advantageous when used with an oval window 112 or a circular window 121. In particular, the oval window 112 and the circular window 121 are each naturally sealed by a membrane. Therefore, if a plug is to be inserted into the oval window 112 or the circular window 121, the membrane must first be opened. Figure 1B and Figure 1C In an embodiment of the present invention, the drug delivery tube 138 has sufficient longitudinal rigidity and / or a suitable distal configuration to pierce / penetrate the membrane so that the fixable inner ear drug delivery plug 150 can be directly inserted through (i.e., pushed through) the membrane. That is, the fixable inner ear drug delivery plug 150 is self-perforating so that the plug can be inserted into the recipient without the need to pre-pierce the membrane using surgical instruments.

[0039] As noted, a fixable inner ear drug delivery plug (such as plug 150) according to embodiments of the present invention includes one or more anchoring features configured to anchor or otherwise substantially permanently secure the plug in the inner ear opening (i.e., to prevent withdrawal or removal of the plug without surgical intervention). Figure 1A and Figure 1B In the embodiment of the present invention, the one or more anchoring features include an annular depression or groove 136 disposed around a portion of the outer body 152. The groove 136 is formed by a stop surface 137 and a distal flange 139 and is configured to cooperate with the inner ear structure surrounding the opening 160.

[0040] More specifically, the distal flange 139 is disposed at the distal end 146 of the fixable intra-ear drug delivery plug 150 and is configured such that an outer dimension (e.g., diameter) 172 of the distal end 146 is greater than an inner dimension (e.g., diameter) 173 of the opening 160. The distal flange 139 is formed of an elastically flexible material such that when the fixable intra-ear drug delivery plug 150 is inserted into the opening 160, the distal flange 139 is configured to be compressed so as to pass through the opening. However, due to the elastic / elastic properties of the distal flange 139, the distal flange 139 is configured to return to the configuration before insertion (non-compressed) after passing through the opening 160. That is, once the distal flange 139 passes through the opening 160, the distal flange 139 "pops open" outward or away from the outer body 152 to return to the configuration before insertion.

[0041] like Figure 1C As shown, after the distal flange 139 passes through the opening 160, the stop surface 137 will contact the outer surface of the inner ear structure 162 to prevent additional forward (distal) movement of the fixable inner ear drug delivery plug 150. When the stop surface 137 contacts the outer surface of the inner ear, the inner ear structure surrounding the opening 160 is locked in the groove 136, where the stop surface 137 prevents additional forward movement, and the distal flange 139 prevents backward (proximal) movement. As a result, the fixable inner ear drug delivery plug 150 is fixed in the opening 160.

[0042] In certain embodiments, the groove 136 may include one or more features that operate to further secure the fixable intra-ear drug delivery plug 150. For example, the groove 136 may be textured to increase friction between the intra-ear structure surrounding the opening 160 and the surface of the groove. Additionally or alternatively, one or more biocompatible adhesives may be disposed in the groove 136.

[0043] Reference has been made to the external body 152 Figure 1B and Figure 1C As described, the outer body 152 is formed of a biocompatible polymer material. It should be appreciated that the outer body 152 may also be formed of, for example, a biocompatible metal (eg, titanium), a ceramic, and / or a combination of these or other materials.

[0044] Figure 1B and Figure 1CThe outer body 152 is also illustrated as having a generally frustoconical or tapered shape, wherein an outer dimension (e.g., width, diameter, etc.) of the outer body 152 generally increases from the distal end 146 to the proximal end 148 (i.e., the outer dimension 170 of the proximal end 248 is greater than the outer dimension 172 of the distal end 146). The frustoconical or tapered shape may also facilitate sealing of the opening 260 by exerting an outward force on the inner ear structures adjacent to the opening 160. Although Figure 1A and Figure 1B While outer body 252 is illustrated as having a frustoconical shape, it will be appreciated that fixable intra-ear drug delivery plugs according to embodiments of the present invention may have other shapes.

[0045] exist Figure 1B and Figure 1C In an embodiment of the present invention, the fixable inner ear drug delivery plug 150 is configured to fill and seal the opening 160 to prevent inner ear fluid from flowing out through the opening (i.e., around the plug). However, it should be appreciated that the plug 150 or other plugs described herein may partially seal the opening 160. In such an embodiment, the fixable inner ear drug delivery plug may be used in conjunction with one or more additional sealing elements and / or a drug that controls tissue growth to seal the opening. In one example, one or more portions of the fixable inner ear drug delivery plug 150 may be pre-loaded (doped) with a drug that promotes tissue growth around the plug. After implantation, the drug may then be eluted from one or more portions of the fixable inner ear drug delivery plug 150.

[0046] In some embodiments, a fixable inner ear drug delivery plug according to embodiments presented herein, such as plug 150, can be refilled after implantation. In one example, a fixable inner ear drug delivery plug according to embodiments presented herein can be refilled via injection through an external body or through a syringe port.

[0047] Figure 2 is a cross-sectional view of another fixable inner ear drug delivery plug 250 according to an embodiment of the present invention. The fixable inner ear drug delivery plug 250 includes an outer body 252 defining an inner region 254. In this embodiment, a drug eluting member 276 is disposed in the inner region 254. Figure 2 Also shown is a permeable membrane 256 and one or more one-way (one-way) fixing plates 258. Figure 2In an embodiment of the invention, the fixable inner ear drug delivery plug 250 has a proximal end 248 and a distal end 244. The distal end 246 is configured to be inserted through an opening 160 in a structure 162 of a recipient's inner ear (i.e., cochlea or semicircular canal) 164, while the proximal end 246 is configured to remain outside (outside) the inner ear. That is, when fully implanted, a first portion 266 of the fixable inner ear drug delivery plug 250 is disposed / positioned outside the inner ear 164, while a second portion 268 of the fixable inner ear drug delivery plug 250 is disposed inside (inside) the inner ear 164 (i.e., the fixable inner ear drug delivery plug 250 is configured to be partially inserted into the inner ear 164).

[0048] In some examples, the size and shape of the outer body 252 are designed to control / limit the depth to which the fixable inner ear drug delivery plug 250 is inserted into the inner ear 164. For example, the outer body 252 can have a generally truncated conical shape or a tapered shape, wherein the outer dimensions (e.g., width, diameter, etc.) of the outer body 252 generally increase from the distal end 246 to the proximal end 248 (i.e., the outer dimension 270 of the proximal end 248 is greater than the outer dimension 272 of the distal end 246). The increase in the outer dimensions of the outer body 252 between the distal end and the proximal end enables the first portion 266 of the fixable inner ear drug delivery plug 250 to be inserted through the opening 160 while preventing the second portion 268 from passing through the opening 160 (i.e., the truncated conical shape or tapered shape of the outer body 252 limits the insertion depth of the plug). In addition to limiting the insertion depth, the truncated conical shape or tapered shape can also facilitate sealing of the opening 160 by exerting an outward force on the inner ear structures adjacent to the opening 160. Although Figure 2 While outer body 252 is illustrated as having a frustoconical shape, it will be appreciated that fixable intra-auricular drug delivery plugs according to embodiments of the present invention may have other shapes to control / limit the insertion depth of the plug.

[0049] As noted, a fixable inner ear drug delivery plug (such as plug 250) according to embodiments of the present invention includes: (1) a passive drug delivery mechanism that delivers the drug directly into the inner ear; and (2) one or more anchoring features configured to anchor or otherwise substantially permanently secure the plug in the inner ear opening. Figure 2 In the embodiment of FIG. 2 , the passive drug delivery mechanism 274 is provided with a permeable membrane 256 and a drug eluting member 276 disposed in the interior region 254. One or more anchoring features are formed by a one-way fixing piece 258.

[0050] Referring first to the passive drug delivery mechanism 274, the drug eluting member 276 is a polymer element pre-loaded (doped) with one or more drugs (i.e., the drug delivery drug eluting member 276 releasably carries one or more drugs). In operation, the drug in the drug eluting member 276 is eluted from the drug eluting member 276 and enters the inner ear 164 via (through) the permeable membrane 256. In particular, the outer body 252 is substantially impermeable to the drug and substantially surrounds the portions of the drug eluting member 276 that are not adjacent to the permeable membrane 256. Therefore, the drug of the drug eluting member 276 is directed through the permeable membrane 256. In certain embodiments, the elution of the drug in the drug eluting member 276 can be caused or activated by, for example, contact with inner ear fluid, temperature increase to the body temperature of the recipient, etc. The outer body 252 and the drug eluting member 276 can each be formed of the same or different polymer materials, such as, for example, polydimethylsiloxane (PDMS).

[0051] As pointed out, Figure 2 The purpose of the drug eluting member 276 disposed in the inner region 254 is illustrated. However, it should be appreciated that in other embodiments, the inner region 254 may define a reservoir, directly filled with a liquid drug or a solid drug, which is configured to change form when placed in contact with the inner ear fluid (via a permeable membrane). In such an embodiment, the drug leaves the reservoir via the permeable membrane 256 and enters the inner ear 164. That is, the permeable membrane 256 seals the reservoir during the plug insertion, but allows the drug to be released after the plug is inserted. For example, the permeable membrane 156 can be configured to change form after implantation in order to release the drug. Due to contact with a fluid (e.g., inner ear fluid) or in response to a temperature change caused by the recipient's body, the permeable membrane 156 can change from a closed / sealed form to a permeable form. In one example, the permeable membrane 256 is a "semi-permeable" membrane that does not change form when in contact with a liquid, but relies on diffusion and gradient effects. In other embodiments, a protective film may be placed over the permeable membrane 256 and removed just prior to or during implantation (preferably together with a drug-carrying fluid having a high viscosity).

[0052] It should be appreciated that the drug eluting member 276 (or reservoir) may include a variety of different types of drugs. That is, according to embodiments of the present invention, a variety of different drugs may be disposed in the interior region 254 for delivery to a recipient.

[0053] Next, with reference to one or more anchoring features, the one-way fixing piece 258 is an element that allows insertion of the plug (i.e., allows movement in the distal direction as illustrated by arrow 275), but resists or prevents withdrawal of the plug (i.e., resists movement in the proximal direction as illustrated by arrow 277). In particular, the one-way fixing piece 258 extends outwardly from the surface of the outer body 252 and has an initial shape and / or orientation. However, as Figure 2 As shown, the one-way fixing piece 258 is configured to be compressed when the one-way fixing piece 258 passes through the opening 160. Therefore, one or more inner ear structures surrounding the opening 160 force the one-way fixing piece 258 to bend backward (i.e., in the proximal direction 277) toward the proximal end 248. However, due to the elastic / resilient properties of the one-way fixing piece 258, the one-way fixing piece is configured to return to the configuration before insertion after passing through the opening 160. That is, once the one-way fixing piece 258 passes through the opening 160, the one-way fixing piece 258 "pops outward" or away from the outer body 252 to return to the configuration before insertion.

[0054] When the one-way fixing pieces 258 pass through the opening 160 and return to their configuration before insertion, the surgeon can apply tension (i.e., pulling force) on the fixable inner ear drug delivery plug 250 in the proximal direction 277. Applying tension forces the one-way fixing pieces 258 to be forced against the surfaces of the inner ear adjacent to the opening 160. In turn, these surfaces apply force on the one-way fixing pieces 258 in the distal direction 275. Although the one-way fixing pieces 258 are configured to bend backward (i.e., in the proximal direction), the one-way fixing pieces 258 are configured so that they are not bent in the forward (distal) direction (e.g., have rigidity in the distal direction). In other words, the one-way fixing pieces 258 engage the inner surface of the inner ear. Therefore, the engagement of the one-way fixing pieces 258 with the surfaces around the opening 160 prevents the fixable inner ear drug delivery plug 250 from moving out of the opening 160 of the inner ear 164 (i.e., fixes the fixable inner ear drug delivery plug 250 in the opening 160). The one-way fixing sheet 258 according to the embodiment of the present invention may be formed of, for example, silicone, polyimide or PEEK, or elastic or resilient metal.

[0055] exist Figure 2 In an embodiment of the present invention, the outer body 252 is resiliently flexible so as to be at least partially compressible during insertion through the opening 160. The compressibility of the outer body 252 can facilitate the insertion of the fixing plate 258 through the opening 160 (i.e., temporarily reducing the outer dimensions of the plug 250 during insertion). However, the compressibility of the outer body 252 can also facilitate the delivery of the drug in the inner region 254 directly into the inner ear 164. More specifically, compressing the outer body 252 after the distal end 246 has passed through the opening 160 can compress the drug eluting member 276 so as to force the drug through the permeable membrane 256.

[0056] Reference has been made to the external body 252 Figure 2 It is described that the outer body 252 is formed of a biocompatible polymer material. It should be appreciated that the outer body 252 can also be formed of, for example, a biocompatible metal (eg, titanium), a ceramic, and / or a combination of these or other materials.

[0057] Figure 2 An example is shown in which the one-way fixing piece 258 is a plurality of discrete (separate) elements disposed at different locations around the outer body 252. In an alternative embodiment, the fixable drug delivery plug 250 may include a single one-way fixing piece. The single one-way fixing piece may include a continuous flange / shaft ring extending around the outer body 252.

[0058] Figure 3 FIG. 1 is a cross-sectional view illustrating another embodiment of the present invention. Figure 3 In the embodiment, the fixable inner ear drug delivery plug 350 has a Figure 2 , including an outer body 252, a drug eluting member 276 and a permeable membrane 256. However, in Figure 3 In the embodiment of the present invention, the outer body 252 includes multiple sets or groups 359(1), 359(2), and 359(3) of longitudinally spaced one-way fixing plates 258. Generally speaking, the three sets 359(1), 359(2), and 359(3) of one-way fixing plates 258 each include one or more one-way fixing plates 258 and together provide the surgeon with the ability to select one of several different insertion depths of the fixable intra-ear drug delivery plug 350. In other words, any one of the sets 359(1), 359(2), and 359(3) can be used to fix the fixable intra-ear drug delivery plug 350 in the opening 160 to accommodate variations in the anatomical structures of different recipients.

[0059] Figure 4 4 is a cross-sectional view of a fixable inner ear drug delivery plug 450 according to an embodiment of the present invention. The fixable inner ear drug delivery plug 450 includes an outer body 452 defining an inner region 454 in which one or more drugs are disposed. Figure 4 In the example of , the interior region 454 is a reservoir for one or more drugs. However, it should be appreciated that in an alternative arrangement, the interior region 454 may include a drug eluting member. Disposed at the distal end 446 of the fixable intra-auricular drug delivery plug 450 is a permeable membrane 456 that seals the reservoir 454 during insertion of the plug, but allows release of the drug after the plug is inserted.

[0060] exist Figure 4In the embodiment of the invention, the fixable inner ear drug delivery plug 450 is configured to be partially inserted into the inner ear 164. That is, the distal end 446 is configured to be inserted through the opening 160, and the proximal end 448 is configured to remain outside the inner ear (i.e., the first portion 466 of the fixable inner ear drug delivery plug 250 is located outside the inner ear 164, and the second portion 468 of the fixable inner ear drug delivery plug 450 is disposed inside the inner ear 164).

[0061] As shown, the size and shape of the outer body 452 is designed to limit the insertion depth of the fixable intraauricular drug delivery plug 450. That is, the outer body 452 has a generally frustoconical or tapered shape, wherein the outer dimensions of the outer body 452 generally increase from the distal end 446 to the proximal end 448. Although Figure 4 While the outer body 452 is illustrated as having a frustoconical shape, it will be appreciated that the fixable intra-ear drug delivery plug 450 may have other shapes.

[0062] exist Figure 4 In the embodiment of the present invention, the fixable inner ear drug delivery plug 450 includes a passive drug delivery mechanism 474 formed by a permeable membrane 456 and a reservoir 454. In operation, the drug in the reservoir 454 exits the reservoir via (through) the permeable membrane 456 and enters the inner ear 164. In particular, the outer body 452 is substantially impermeable to the drug, so that the drug is guided through the permeable membrane 456.

[0063] The fixable inner ear drug delivery plug 450 includes one or more anchoring features in the form of threads 480 disposed around the outer body 452. Thus, the outer body 452 includes a threaded body (stem) configured to be inserted (e.g., screwed) into the opening 160. The threads 480 interact (engage) with the wall surrounding the opening 160 to retain the fixable inner ear drug delivery plug 450 in the opening.

[0064] exist Figure 4 In the example of the embodiment of the present invention, the outer body 452 and the threads 480 are formed of a resiliently flexible material (e.g., silicone) such that the body and threads are partially compressed when placed in contact with the wall surrounding the opening 160 (i.e., when screwed into the opening). The compression threads further secure the fixable intra-ear drug delivery plug 450 in the opening 160, and also operate to seal the opening 160 to prevent leakage of intra-ear fluid past the plug.

[0065] although Figure 4While an embodiment is illustrated in which the outer body 452 and the threads 480 are formed of a resiliently flexible material, it should be appreciated that in other embodiments, the outer body 452 and the threads 480 may be formed of different materials. For example, the outer body 452 and the threads 480 may be formed of a substantially rigid material (e.g., titanium) that is configured to bond with the wall surrounding the opening 160. In such an embodiment, the threads are integrated with the wall surrounding the opening 160 to secure the fixable intra-ear drug delivery plug in the opening and also seal the opening to prevent leakage of intra-ear fluid past the plug.

[0066] Figure 5A and Figure 5B is a cross-sectional view of a fixable inner ear drug delivery plug 550 according to an embodiment of the present invention. Figure 5A The secureable inner ear drug delivery plug 550 is shown just after being inserted into the inner ear opening 160. Figure 5B The fixable inner ear drug delivery plug 550 is illustrated at a later time (ie, some time after initial insertion).

[0067] The fixable inner ear drug delivery plug 550 includes an outer body 552 defining an interior region 554 in which one or more drugs are disposed. Figure 5A and Figure 5B In the example of FIG. 5 , the interior region 554 is a reservoir for one or more drugs. However, it should be appreciated that in an alternative arrangement, the interior region 554 may include a drug eluting member.

[0068] exist Figure 5A and Figure 5B In the embodiment of the invention, the fixable inner ear drug delivery plug 550 is configured to be partially inserted into the inner ear 164. That is, the distal end 546 is configured to be inserted through the opening 160, while the proximal end 548 is configured to remain outside the inner ear. As shown, the size and shape of the outer body 552 are designed to limit the insertion depth of the fixable inner ear drug delivery plug 550. That is, the outer body 552 has a generally truncated conical shape or a tapered shape, wherein the outer dimensions of the outer body 552 generally increase from the distal end 546 to the proximal end 548. Although Figure 5A and Figure 5B While the outer body 552 is illustrated as having a frustoconical shape, it will be appreciated that the fixable intra-auricular drug delivery plug 550 may have other shapes.

[0069] The fixable inner ear drug delivery plug 550 includes one or more anchoring features in the form of an expandable component 582. Figure 5BAs shown, the expandable component 582 is a component configured to expand (e.g., bulge) when exposed to the recipient's inner ear fluid (such as perilymph or endolymph). That is, after being inserted into the inner ear 164, the expandable component 582 is allowed to accept the inner ear fluid (i.e., the fluid penetrates the matrix and the material bulges) so as to reach an outer dimension 570 after insertion that is larger than the inner dimension 573 of the opening 160. The larger outer dimension 570 of the expandable component 582 prevents the fixable inner ear drug delivery plug 550 from moving (i.e., the expandable component 582 engages the inner surface in the inner ear to prevent the plug from being withdrawn). In some examples, when the expandable component 582 is in an expanded (enlarged) configuration, the expandable component is configured to exert a force on the inner ear structure surrounding the opening 160 so as to further lock the fixable inner ear drug delivery plug 550 in the opening.

[0070] The expandable component 582 can be formed of different materials and have different arrangements. In one embodiment, the expandable component 582 is a polymer material configured to swell (i.e., expand) when exposed to the recipient's body fluids. In another embodiment, the expandable component 582 is a dry and compressed sponge configured to absorb inner ear fluids after insertion.

[0071] Figure 5A and Figure 5B Particular arrangements are illustrated in which the impermeable membrane 586 is part of the expandable component 582. In these embodiments, the impermeable membrane 586 is located between the expandable component 582 and the inner surface of the recipient's inner ear structure adjacent to the opening 160. Thus, when the expandable component 582 expands, the impermeable membrane 586 can be compressed between the expandable component 582 and the inner surface of the recipient's inner ear structure to reduce / avoid leakage of inner ear fluid through the opening 160.

[0072] exist Figure 5A and Figure 5B In an embodiment of the invention, the fixable inner ear drug delivery plug 550 includes a passive drug delivery mechanism 574 formed by a reservoir 554 and an expandable component 582. In operation, one or more drugs in the reservoir 554 leave the reservoir and enter the inner ear via (through) the expandable component 582. In an alternative arrangement, one or more drug delivery tubes can extend through the expandable component 582 to bypass the expandable component 582 and facilitate the delivery of one or more drugs in the reservoir 554.

[0073] Fig. 6A and Figure 6B is a cross-sectional view of a fixable inner ear drug delivery plug 650, which is similar to Figure 5A and Figure 5B Plug 550 is shown in FIG. Fig. 6AThe secureable inner ear drug delivery plug 650 is shown just after being inserted into the inner ear opening 160. Figure 6B The fixable inner ear drug delivery plug 650 is illustrated at a later time (ie, some time after initial insertion).

[0074] The fixable inner ear drug delivery plug 650 includes an outer body 652 defining an interior region 654 in which one or more drugs are disposed. Fig. 6A and Figure 6B In the example of FIG. 6A , the interior region 654 is a reservoir for one or more drugs. However, it should be appreciated that in an alternative arrangement, the interior region 654 may include a drug eluting member.

[0075] exist Fig. 6A and Figure 6B In the embodiment of the invention, the fixable inner ear drug delivery plug 650 is configured to be partially inserted into the inner ear 164. That is, the distal end 646 is configured to be inserted through the opening 160, while the proximal end 648 is configured to remain outside the inner ear. As shown, the size and shape of the outer body 652 are designed to limit the insertion depth of the fixable inner ear drug delivery plug 650. That is, the outer body 652 has a generally truncated conical shape or a tapered shape, wherein the outer dimensions of the outer body 652 generally increase from the distal end 646 to the proximal end 648. Although Fig. 6A and Figure 6B While the outer body 652 is illustrated as having a frustoconical shape, it will be appreciated that the fixable intra-ear drug delivery plug 650 may have other shapes.

[0076] The fixable inner ear drug delivery plug 650 includes one or more anchoring features in the form of two or more expandable components 682. Figure 6B As shown, the expandable component 682 is configured to expand (e.g., bulge) when exposed to the recipient's inner ear fluid. That is, the expandable component 682 accepts the inner ear fluid (i.e., the fluid penetrates the matrix and the material expands) so that the distal end 646 reaches an outer dimension 670 after insertion, which is larger than the inner dimension 673 of the opening 160. The larger outer dimension 670 of the distal end 646 prevents the fixable inner ear drug delivery plug 650 from moving. In some examples, the expandable component 682, when in the expanded (enlarged) configuration, is configured to exert a force on the inner ear structure surrounding the opening 160 to further lock the fixable inner ear drug delivery plug 650 in the opening.

[0077] The expandable component 682 can be formed of several different materials and can have a variety of different arrangements. In one embodiment, the expandable component 682 is formed of a polymer material and is configured to swell (i.e., expand) when exposed to the recipient's body fluids. In another embodiment, the expandable component 682 is a dry and compressed sponge configured to absorb inner ear fluids after insertion.

[0078] exist Fig. 6A and Figure 6B In the embodiment of the invention, the fixable inner ear drug delivery plug 650 includes a passive drug delivery mechanism 674 formed by a reservoir 654 and a permeable membrane 656 disposed at the distal end of the reservoir. In operation, one or more drugs in the reservoir 654 leave the reservoir via (through) the permeable membrane 656 and enter the inner ear 164.

[0079] Fig. 7A and Figure 7B is a cross-sectional view of another fixable inner ear drug delivery plug 750, which also includes an expandable component. Fig. 7A The secureable inner ear drug delivery plug 750 is shown just after being inserted into the inner ear opening 160. Figure 7B The fixable inner ear drug delivery plug 750 is illustrated at a later time (ie, some time after initial insertion).

[0080] The fixable inner ear drug delivery plug 750 includes an outer body 752 defining an interior region 754 in which one or more drugs are disposed. Fig. 7A and Figure 7B In the example of FIG. 7 , the interior region 754 is a reservoir for one or more drugs. However, it should be appreciated that in an alternative arrangement, the interior region 754 may include a drug eluting member.

[0081] exist Fig. 7A and Figure 7B In the embodiment of the invention, the fixable inner ear drug delivery plug 750 is configured to be partially inserted into the inner ear 164. That is, the distal end 746 is configured to be inserted through the opening 160, while the proximal end 748 is configured to remain outside the inner ear. As shown, the size and shape of the outer body 752 are designed to limit the insertion depth of the fixable inner ear drug delivery plug 750. That is, the outer body 752 has a generally truncated conical shape or a tapered shape, wherein the outer dimensions of the outer body 752 generally increase from the distal end 746 to the proximal end 748. Although Fig. 7A and Figure 7B While the outer body 752 is illustrated as having a frustoconical shape, it will be appreciated that the fixable intra-ear drug delivery plug 750 may have other shapes.

[0082] The fixable inner ear drug delivery plug 750 includes one or more anchoring features in the form of an expandable component 782. The expandable component 782 is a memory material element (e.g., a nitinol wire) that is configured to expand when heated to the body temperature of the recipient. Figure 7B As shown, the expandable component 782 expands when heated to the recipient's body temperature so as to have an outer dimension 770 that is larger than the inner dimension of the opening 160, thereby preventing the fixable inner ear drug delivery plug 750 from moving. In some examples, the expandable component 782, when in the expanded (enlarged) configuration, is configured to exert a force on the inner ear structure surrounding the opening 160 to further lock the fixable inner ear drug delivery plug 750 in the opening.

[0083] exist Fig. 7A and Figure 7B In the embodiment of the invention, the fixable inner ear drug delivery plug 750 includes a passive drug delivery mechanism 774 formed by a reservoir 754 and a permeable membrane 756 disposed at the distal end of the reservoir. In operation, one or more drugs in the reservoir 754 leave the reservoir via (through) the permeable membrane 756 and enter the inner ear 164.

[0084] In general, FIG. 5A to FIG. 7B A fixable inner ear drug delivery plug is illustrated, including one or more anchoring structures in the form of a component configured to expand after the plug is inserted into an opening in the inner ear. These expandable anchoring features are located at the distal end of the associated plug and are configured to prevent the plug from being removed / withdrawn through the inner ear opening.

[0085] Fig. 8A and Figure 8B is a cross-sectional view illustrating another fixable inner ear drug delivery plug 850 and a mechanism for delivering the plug according to an embodiment of the present invention. Fig. 8A The fixable inner ear drug delivery plug 850 is shown prior to insertion into the inner ear opening 160, and Figure 8B The inner ear drug delivery plug 850 is illustrated just after insertion into the inner ear opening 160 .

[0086] Similar to the arrangements described above, the fixable inner ear drug delivery plug 850 includes an outer body 852 defining an inner region 854 forming a reservoir for one or more drugs. Disposed at the distal end 846 of the outer body 852 is a permeable membrane 856 and one or more tabs or flanges 858.

[0087] like Fig. 8AAs shown, the fixable inner ear drug delivery plug 850 is initially positioned in the plug delivery tube 887. The delivery tube 887 is sized to fit into the inner ear opening 160, and to compress the outer body 852 and the flange 858. During insertion, the distal end 889 of the delivery tube 887 is inserted through the opening 160. Then, the plunger 890 is used to push the fixable inner ear drug delivery plug 850 in the forward direction / distal direction 875 to at least force the distal end 846 of the fixable inner ear drug delivery plug 850 out of the distal end 889 of the delivery tube 887. When the distal end 846 of the fixable inner ear drug delivery plug 850 leaves the distal end 889 of the delivery tube 887, the flange 858 expands to a configuration where the outer dimensions are larger than the inner dimensions of the opening 160, thereby preventing the proximal movement (i.e., movement along the direction 877) of the fixable inner ear drug delivery plug 850. Flange 858 may be a silicone component, a metal spring, or any other element that may be compressed during insertion through delivery tube 887 .

[0088] Once at least the distal end 846 of the fixable intra-ear drug delivery plug 850 is clear of the distal end 889 of the delivery tube 887, the delivery tube is withdrawn (ie, moved in the proximal direction 877) from the opening 160. The delivery tube 887 and plunger 890 may then be removed from the recipient.

[0089] As noted, the outer body 852 is also compressed when positioned in the delivery tube 887. Thus, removing the delivery tube 887 allows the outer body 852 to expand so as to substantially fill the opening 160.

[0090] exist Fig. 8A and Figure 8B In the embodiment of the invention, the fixable inner ear drug delivery plug 850 includes a passive drug delivery mechanism 874 formed by a reservoir 854 and a permeable membrane 856 disposed at the distal end of the reservoir. In operation, one or more drugs in the reservoir 854 leave the reservoir via (through) the permeable membrane 856 and enter the inner ear 164.

[0091] Fig.9A and Fig. 9B is a cross-sectional view of a two-stage or two-part fixable inner ear drug delivery plug 950 according to an embodiment of the present invention. In particular, the fixable inner ear drug delivery plug 950 includes a main member 993 and a compressible buckle 993, which is formed of, for example, biocompatible rubber or other compressible materials.

[0092] The main component 993 includes an outer body 952 defining an interior region 954 that forms a reservoir for one or more drugs. Disposed at the distal end 946 of the outer body 952 is a permeable membrane 956. The reservoir 954 and the permeable membrane 956 disposed at the distal end of the outer body 952 serve as a drug delivery mechanism 974.

[0093] like Fig.9A As shown, the compressible buckle 995 includes an annular depression or groove 936 disposed around the outer surface of the buckle. When the buckle 995 is disposed in the opening 160, the groove 936 is configured to cooperate with the inner ear structure surrounding the opening 160.

[0094] The buckle 995 has a lumen 996 extending therethrough. Fig. 9B As shown, the main member 993 is configured to be inserted into the lumen 996 and is configured to exert an outward force on the compressible buckle 995 to secure the main member 993 in the lumen 996 and, therefore, in the opening 160. That is, in Fig.9A and Fig. 9B In an embodiment of the present invention, the outer body 952 is formed of a material that is substantially rigid relative to the buckle 995, so that the buckle is compressed between the inner ear structure surrounding the opening 160 and the outer body 952. The compression buckle 995 is used to fix the main member 993 in the lumen 966, and therefore in the opening 160 (i.e., the compressible buckle 995 is an anchoring feature). In addition, the compression buckle 995 is used to substantially seal the opening 160, thereby preventing inner ear fluid from leaking around the plug 950.

[0095] In some examples, an interface may be provided between the main member 993 and the buckle 995. The interface may be, for example, a screw interface, an interlocking interface, etc. The interface may allow replacement of the reservoir if, for example, more or another drug is needed. In addition, the interlocking interface may be used later to anchor the intracochlear stimulation assembly as desired.

[0096] Fig.10 1 is a cross-sectional view of another fixable inner ear drug delivery plug 1050 according to an embodiment of the present invention. The fixable inner ear drug delivery plug 1050 includes an outer body 1052, defining an inner area 1054, which forms a reservoir for one or more drugs. Disposed at the distal end 1046 of the outer body 1052 is a rotatable disk 1097, which is mechanically attached to a rotating arm 1098. The rotating arm 1098 extends longitudinally from the rotatable disk 1097 through the proximal end 1048 of the fixable inner ear drug delivery plug 1050 so that the surgeon can approach and actuate / manipulate the rotating arm 1098.

[0097] like Fig.10As shown, the fixable inner ear drug delivery plug 1050 is configured to be partially inserted into the inner ear 164. That is, the distal end 1046 is configured to be inserted through the opening 160, and the proximal end 1048 is configured to remain outside the inner ear 164. As shown, the size and shape of the outer body 1052 are designed to limit the insertion depth of the fixable inner ear drug delivery plug 1050 (e.g., the outer body 1052 has a generally truncated conical shape or a tapered shape).

[0098] Once the fixable intra-ear drug delivery plug 1050 is fully inserted into the opening 160, the rotation arm 1098 can be actuated to rotate the disk 1097 (e.g., asymmetrically) in the general direction indicated by arrow 1099. After rotation, the rotatable disk 1097 is positioned adjacent to the intra-ear structure surrounding the opening 160 to prevent the fixable intra-ear drug delivery plug 1050 from moving in the proximal direction.

[0099] exist Fig.10 In the specific example of the embodiment of the present invention, the rotatable disk 1097 is also a cover for the reservoir 1054. Therefore, the reservoir 1054 and the rotatable disk 1097 together serve as the drug delivery mechanism 1074 of the fixable inner ear drug delivery plug 1050. However, it should be appreciated that in other embodiments, the rotatable disk 1097 may not cover the reservoir 1054. For example, in an alternative embodiment, the rotatable disk 1097 may only cover a portion of the distal end of the reservoir 1054. In such an embodiment, the fixable inner ear drug delivery plug 1050 may include one or more other mechanisms (e.g., a permeable membrane) that operate to control the delivery of the drug from the reservoir 1054 to the inner ear (i.e., other elements form part of the drug delivery mechanism). It should also be appreciated that the use of one rotatable disk 1097 is illustrative, and other embodiments may use multiple rotatable disks to fix the plug in the inner ear opening.

[0100] It should be understood that, unlike Fig.10 Arrangements other than the one shown in are possible. For example, the reservoir may be secured by, for example, prongs / flanges (as described above), while the rotatable disc is used to provide drug delivery, since it may be partially opened (to administer a lower dose) or fully opened (to give a high dose). In other words, Fig.10 The arrangement may include other anchoring features, and the rotatable disc is primarily used for drug delivery.

[0101] The above description illustrates various embodiments for a fixable inner ear drug delivery plug according to embodiments of the present invention. It should be appreciated that the above embodiments are not mutually exclusive, and the various embodiments can be combined in various ways and arrangements. That is, the drug delivery mechanisms and anchoring features described above can be combined and used in a variety of different combinations. It should also be appreciated that other embodiments of drug delivery mechanisms and anchoring features are also within the scope of the present invention. For example, an embodiment may include an expandable component in the form of a fork / flange (e.g., a deflated flange / inflatable flange) that can be deployed after the fixable inner ear drug delivery plug is inserted into the inner ear opening.

[0102] In addition, it should be appreciated that, in addition to one or more anchoring features, there are also auxiliary fixing mechanisms that can be used in certain embodiments. These auxiliary fixing mechanisms can include biocompatible adhesives (e.g., bonding agents) applied to one or more parts of the plug. The bone agent can be, for example, ionomer bone cement or polymethylmethacrylate (PMMA) bone cement. In other embodiments, the adhesive can be any biocompatible adhesive known now or developed later. In certain embodiments, the adhesive can be configured to be reabsorbed by the recipient's tissue / bone after the recipient's tissue / bone is encapsulated by fibrosis.

[0103] In further embodiments, the fixable inner ear drug delivery plug may be formed of a material configured to harden when exposed to ultraviolet (UV) light. In such embodiments, after the fixable inner ear drug delivery plug is positioned in the inner ear opening, UV light may be delivered.

[0104] The invention described and claimed herein is not limited to the scope of the specific preferred embodiments disclosed herein, because these embodiments are intended to illustrate but not to limit several aspects of the present invention. Any equivalent embodiments are within the scope of the present invention. In fact, various modifications of the present invention will become apparent to those skilled in the art from the preceding description, except those shown and described herein. These modifications are also intended to fall within the scope of the appended claims.

Claims

1. A fixable inner ear drug delivery plug, comprising: a body for insertion into an opening in an inner ear of a recipient; at least one passive drug delivery mechanism configured to deliver one or more drugs directly into the inner ear via the body; as well as A thread extends along the outer surface of the body and is configured to be screwed into the opening of the inner ear to mechanically cooperate with the surface of the inner ear structure surrounding the opening of the inner ear to fluidly seal the opening of the inner ear to prevent inner ear fluid from flowing out through the opening of the inner ear via the thread, wherein the thread includes a rigid material configured to combine with the inner ear structure surrounding the opening in the inner ear of the recipient.

2. A fixable inner ear drug delivery plug according to claim 1, wherein the body has an elongated frustoconical shape.

3. The fixable inner ear drug delivery plug according to claim 1, further comprising: A drug eluting member is disposed in the body.

4. The fixable inner ear drug delivery plug of claim 1, wherein the body defines a plurality of reservoirs, each of the plurality of reservoirs being configured to have at least one drug located therein.

5. The fixable inner ear drug delivery plug of claim 1, wherein the body defines a reservoir for one or more drugs.

6. The fixable inner ear drug delivery plug according to claim 5, further comprising: A membrane is located at the distal end of the reservoir, wherein the membrane is configured to seal the reservoir during insertion of the body into the opening and the membrane is configured to allow release of the one or more drugs after the body is inserted into the opening.

7. The fixable inner ear drug delivery plug according to claim 5, further comprising: One or more drug delivery tubes extend from the reservoir through the distal end of the body to provide a pathway for the one or more drugs to exit the reservoir and enter the inner ear.

8. A fixable inner ear drug delivery plug according to claim 7, wherein the opening in the inner ear is a natural opening including a membrane, and wherein the one or more drug delivery tubes have a distal configuration and longitudinal rigidity to penetrate the membrane.

9. A fixable inner ear drug delivery plug according to claim 7, wherein the inner surface of each of the one or more drug delivery tubes has a surfactant to control the release rate of the one or more drugs from the reservoir.

10. The fixable inner ear drug delivery plug of claim 5, wherein the reservoir is refillable.

11. A fixable inner ear drug delivery plug according to claim 10, wherein the body includes a syringe port for refilling the reservoir.

12. A fixable inner ear drug delivery plug according to claim 6, wherein the reservoir is configured to be refillable with one or more of a liquid drug or a solid drug, wherein the liquid drug or the solid drug is configured to change form when placed in contact with inner ear fluid via a permeable membrane.

13. The fixable inner ear drug delivery plug of claim 6, wherein the membrane is a bioabsorbable membrane.

14. The fixable inner ear drug delivery plug of claim 6, wherein the membrane is a permeable membrane.

15. The fixable inner ear drug delivery plug of claim 14, wherein the permeable membrane is configured to change from a sealed form to a permeable form due to contact with inner ear fluid within the inner ear of the recipient.

16. The fixable inner ear drug delivery plug of claim 14, wherein the permeable membrane is configured to change from a sealed form to a permeable form in response to a temperature change induced by the inner ear of the recipient.